title: Combining Oxymatrine or Matrine with Lamivudine Increased Its Antireplication Effect against the Hepatitis B Virus In Vitro.
abstract: Some recent clinical reports have shown that the combination of oxymatrine, a phyto-derived drug, with lamivudine (3TC) could improve its curative effect against hepatitis B virus (HBV) infection. However, the experimental data in support of this combination strategy are lacking. In this study, we investigated the anti-HBV activity of the combination of 3TC and either oxymatrine or matrine on HepG2 2.2.15 in vitro. The activities of the combination and the solo compound, each in different concentrations, were compared on the 3rd, 6th, and 9th experimental days. The cytotoxicity results showed that the nontoxic concentrations of both oxymatrine and matrine to HepG2 2.2.15 cells were 800 μg/mL. We found that the single use of oxymatrine below 100 μg/ml, matrine below 200 μg/ml, and 3TC below 30 μg/ml showed weak inhibitory effects on the secretion of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and HBV-DNA in culture media; the combination of 3TC (30 μg/ml) with oxymatrine (100 μg/ml) or matrine (100 μg/ml) showed significant inhibitory effects that were higher than or equivalent to the single use of 3TC at 100 μg/ml. The results provide a new impetus to develop novel, multicomponent anti-HBV drugs through the combination of natural products with nucleoside analogs to enhance their activity.
authors: China Military Institute of Chinese Medicine, 302 Military Hospital, Beijing 100039, China ; College of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichnan 610075, China.
authors: Zhi-Jie
authors: ZJ
authors: Ma
authors: Qi
authors: Q
authors: Li
authors: Jia-Bo
authors: JB
authors: Wang
authors: Yan-Ling
authors: YL
authors: Zhao
authors: Yan-Wei
authors: YW
authors: Zhong
authors: Yun-Feng
authors: YF
authors: Bai
authors: Rui-Lin
authors: RL
authors: Wang
authors: Jian-Yu
authors: JY
authors: Li
authors: Hui-Yin
authors: HY
authors: Yang
authors: Ling-Na
authors: LN
authors: Zeng
authors: Shi-Biao
authors: SB
authors: Pu
authors: Fei-Fei
authors: FF
authors: Liu
authors: Da-Ke
authors: DK
authors: Xiao
authors: Xin-Hua
authors: XH
authors: Xia
authors: Xiao-He
authors: XH
authors: Xiao
references: Zhongguo Yao Li Xue Bao. 1996 May;17(3):259-61
references: 9812752
references: Semin Liver Dis. 2010 Nov;30(4):361-77
references: 20960376
references: Hepatology. 2009 Sep;50(3):661-2
references: 19714720
references: Mol Interv. 2007 Aug;7(4):216-23
references: 17827442
references: Minerva Gastroenterol Dietol. 2009 Mar;55(1):5-22
references: 19212304
references: Biosci Trends. 2010 Apr;4(2):39-47
references: 20448340
references: J Hepatol. 2009 Aug;51(2):403-10
references: 19467727
references: Acta Pharmacol Sin. 2001 Feb;22(2):183-6
references: 11741525
references: J Hepatol. 2012 Jul;57(1):167-85
references: 22436845